Elizabeth Faust
Director/Board Member presso BIOMEA FUSION, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Elizabeth A.
Faust is an Independent Director at Biomea Fusion, Inc. She previously worked as an Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc., Vice President-Medical Affairs at Pharmacyclics LLC, Vice President-Medical Affairs at Kite Pharma, Inc., and Executive Vice President-Medical Affairs at Tricida, Inc. Faust holds a doctorate from the University of California, Los Angeles, an undergraduate degree from Auburn University, and a graduate degree from the University of California, Riverside.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOMEA FUSION INC
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Elizabeth Faust
| Società | Posizione | Inizio |
|---|---|---|
| BIOMEA FUSION, INC. | Director/Board Member | 01/06/2022 |
Precedenti posizioni note di Elizabeth Faust
| Società | Posizione | Fine |
|---|---|---|
| TRICIDA, INC. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | - |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2015 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Chief Tech/Sci/R&D Officer | 01/05/2010 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Elizabeth Faust
| University of California, Los Angeles | Doctorate Degree |
| Auburn University | Undergraduate Degree |
| University of California, Riverside | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Elizabeth Faust
